Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02743832` - A Study on Tumor Budding Guiding Individualized Surgical Planning of Early-stage Oral Squamous Cell Carcinoma.	N/A
Active, not recruiting	`NCT02229656` - Olaparib and Radiotherapy in Head and Neck Cancer	Phase 1
Completed	`NCT00389727` - Simultaneous Integrated Boost (SIB)- IMRT	Phase 2
Recruiting	`NCT02328391` - STUDY OBSERVATIONAL OF ERLOTINIB AS SECOND LINE TREATMENT IN PATIENTS WITH SQUAMOUS NSCLC AND EGFR NATIVE	N/A
Completed	`NCT00534950` - Randomized Multicenter Study of 5 vs 6 Weekly Fraction of RT in the Treatment of SCC of the Head and Neck	N/A
Completed	`NCT00875381` - Analysis of Melanocytes (Pigment Cells) in Sun-Exposed Skin	N/A
Terminated	`NCT00073450` - Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530)	Phase 2
Terminated	`NCT01441128` - -02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer	Phase 1
Recruiting	`NCT05970497` - A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors	Phase 1
Completed	`NCT01362127` - Neoadjuvant Chemotherapy Versus Radiochemotherapy for Cancer of the Esophagus or Cardia	Phase 2
Completed	`NCT00240682` - Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFR	Phase 2
Terminated	`NCT02254044` - Dose Escalation of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck or Esophagus	Phase 1
Active, not recruiting	`NCT00829192` - Phase II AK Study in Organ Transplant Patients	Phase 2
Completed	`NCT00539630` - TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN	Phase 3
Completed	`NCT00313027` - Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation	N/A
Recruiting	`NCT04564989` - Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
Not yet recruiting	`NCT06094829` - Tobacco and Alcohol Influence on Oncogenic Drivers and Somatic Evolution in the Oral Mucosa
Recruiting	`NCT04481256` - TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY	N/A
Recruiting	`NCT06295809` - A Study of (Neo)Adjuvant V940 and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007)	Phase 2/Phase 3
Active, not recruiting	`NCT02664935` - National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer	Phase 2

NCT number	NCT02438995
Study type	Interventional
Source	Northwell Health
Contact
Status	Terminated
Phase	Phase 1
Start date	May 2015
Completion date	June 2021

Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms